NSRX Stock Analysis: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$3.10
-0.16 (-4.91%)
▼
5d:
+2.65%
30d:
+14.81%
90d:
-38.0%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Jun 24, 2026
20d
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NSRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NSRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $3.10, which is considered slightly high relative to its 30-day fair value range of $2.75 to $3.20.
Technical Outlook: Technically, NSRX is in a strong downtrend. Immediate support is located at $2.71, while resistance sits at $3.68. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: NSRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.67 (+534.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NSRX is in a strong downtrend. Immediate support is located at $2.71, while resistance sits at $3.68. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: NSRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.67 (+534.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.75 -
$3.20
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 534.4% below Wall St target ($19.67)
Trading Range Analysis
30-Day Trading Range
$2.75 -
$3.20
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.71
Resistance Level
$3.68
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.35
Wall Street Target
$19.67
(+534.4%)
Share & Embed Analysis
Last updated: June 03, 2026 6:54 PM ET
Data refreshes hourly during market hours. Next update: 7:54 PM
Data refreshes hourly during market hours. Next update: 7:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1211 | 59 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 57 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$253 | 66 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$352 | 65 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$219 | 55 HOLD |